Indian API Makers Gain Ground as Global Buyers Diversify Supply Chains

Three Indian pharmaceutical companies are strengthening their position in the global active pharmaceutical ingredients market as customers look beyond China for reliable supplies. These firms benefit from expanded manufacturing capacity, regulatory approvals, and long-term contracts with global drugmakers. Industry analysts note that consistent quality, cost competitiveness, and government support are helping Indian API producers capture higher export share and improve earnings visibility.